PURE Bioscience, Inc. (PURE) Return on equity 2017–2023
PURE Bioscience, Inc. (PURE) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-1456.2%FY2023 · since FY2017: -485.5% → -1456.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -1456.2% | -1366.9 pp |
| FY2022 | -89.3% | -19.7 pp |
| FY2021 | -69.6% | -69.7 pp |
| FY2020 | 0.1% | +550.8 pp |
| FY2019 | -550.8% | +30.2 pp |
| FY2018 | -581.0% | -95.4 pp |
| FY2017 | -485.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More PURE financial trends
PURE RevenuePURE Net incomePURE Net marginPURE Gross profitPURE Gross marginPURE Operating incomePURE Operating marginPURE Operating cash flowPURE Free cash flowPURE Capital expendituresPURE Stock buybacksPURE Dividends paidPURE Total assetsPURE Total liabilitiesPURE Shareholders’ equityPURE overview →